Previous studies revealed the aberrant expression of CD70 in several hematological malignancies and solid malignant tumors, including lung cancer, renal cell carcinoma, glioblastoma osteosarcoma, nasopharyngeal carcinoma and ovarian carcinoma (6, 39–44),. Here, CD70 is linked to renal cell carcinoma.